Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses

American Journal of Pathology

Volumn 183, Issue 4, 2013, Pages 1197-1208

  Fang, Feng ^a   Shangguan, Anna J ^a   Kelly, Kathleen ^a   Wei, Jun ^a   Gruner, Katherine ^a   Ye, Boping ^b   Wang, Wenxia ^a   Bhattacharyya, Swati ^a   Hinchcliff, Monique E ^a   Tourtellotte, Warren G ^a   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; MESSENGER RNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROGENESIS; GENE DELETION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; UPREGULATION; WOUND HEALING;

ADULT; ANIMALS; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 1; EARLY GROWTH RESPONSE PROTEIN 2; EARLY GROWTH RESPONSE PROTEIN 3; FEMALE; FIBROBLASTS; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884571580     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.016     Document Type: Article

References (59)

1. S.A. Jimenez, and C.T. Derk Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis Ann Intern Med 140 2004 37 50
2. A. Gabrielli, E.V. Avvedimento, and T. Krieg Scleroderma N Engl J Med 360 2009 1989 2003
3. D.J. Abraham, and J. Varga Scleroderma: from cell and molecular mechanisms to disease models Trends Immunol 26 2005 587 595
4. J. Varga, and B. Pasche Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis Curr OpinRheumatol 20 2008 720 728
5. C.H. Heldin, M. Landstrom, and A. Moustakas Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition Curr Opin Cell Biol 21 2009 166 176
6. G. Thiel, and G. Cibelli Regulation of life and death by the zinc finger transcription factor Egr-1 J Cell Physiol 193 2002 287 292
7. K.J. O'Donovan, W.G. Tourtellotte, J. Millbrandt, and J.M. Baraban The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience Trends Neurosci 22 1999 167 173
8. B. Christy, and D. Nathans DNA binding site of the growth factor-inducible protein Zif268 Proc Natl Acad Sci U S A 86 1989 8737 8741
9. V.P. Sukhatme, S. Kartha, F.G. Toback, R. Taub, R.G. Hoover, and C.H. Tsai-Morris A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens Oncogene Res 1 1987 343 355
10. F. Fang, K. Ooka, S. Bhattacharyya, J. Wei, M. Wu, P. Du, S. Lin, F. Del Galdo, C.A. Feghali-Bostwick, and J. Varga The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-beta that is up-regulated in systemic sclerosis and mediates profibrotic responses Am J Pathol 178 2011 2077 2090
11. K.J. O'Donovan, E.P. Wilkens, and J.M. Baraban Sequential expression of Egr-1 and Egr-3 in hippocampal granule cells following electroconvulsive stimulation J Neurochem 70 1998 1241 1248
12. S. Bhattacharyya, F. Fang, W. Tourtellotte, and J. Varga Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis) J Pathol 229 2013 286 297
13. W.G. Tourtellotte, R. Nagarajan, A. Bartke, and J. Milbrandt Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis Mol Cell Biol 20 2000 5261 5268
14. X. Gao, R.L. Daugherty, and W.G. Tourtellotte Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators Mol Cell Neurosci 36 2007 501 514
15. L. Li, S.H. Yun, J. Keblesh, B.L. Trommer, H. Xiong, J. Radulovic, and W.G. Tourtellotte Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory Mol Cell Neurosci 35 2007 76 88
16. W.G. Tourtellotte, C. Keller-Peck, J. Milbrandt, and J. Kucera The transcription factor Egr3 modulates sensory axon-myotube interactions during muscle spindle morphogenesis Dev Biol 232 2001 388 399
17. W.G. Tourtellotte, and J. Milbrandt Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3 Nat Genet 20 1998 87 91
18. S. Li, T. Miao, M. Sebastian, P. Bhullar, E. Ghaffari, M. Liu, A.L. Symonds, and P. Wang The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells Immunity 37 2012 685 696
19. B. Gao, Q. Kong, K. Kemp, Y.S. Zhao, and D. Fang Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance Proc Natl Acad Sci U S A 109 2012 899 904
20. Y. Albert, J. Whitehead, L. Eldredge, J. Carter, X. Gao, and W.G. Tourtellotte Transcriptional regulation of myotube fate specification and intrafusal muscle fiber morphogenesis J Cell Biol 169 2005 257 268
21. J. Varga, D. Brenner, and S.H. Phan Fibrosis Research: Methods and Protocols 2005 Humana Press Totowa, NJ
22. X. Yang, J.J. Letterio, R.J. Lechleider, L. Chen, R. Hayman, H. Gu, A.B. Roberts, and C. Deng Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta EMBO J 18 1999 1280 1291
23. F. Fang, A.J. Flegler, P. Du, S. Lin, and C.V. Clevenger Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer Am J Pathol 174 2009 297 308
24. S. Bhattacharyya, S.J. Chen, M. Wu, M. Warner-Blankenship, H. Ning, G. Lakos, Y. Mori, E. Chang, C. Nihijima, K. Takehara, C. Feghali-Bostwick, and J. Varga Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma Am J Pathol 173 2008 1085 1099
25. M. Wu, D.S. Melichian, E. Chang, M. Warner-Blankenship, A.K. Ghosh, and J. Varga Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma Am J Pathol 174 2009 519 533
26. C. Buttner, A. Skupin, and E.P. Rieber Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences J Cell Physiol 198 2004 248 258
27. B.H. Min, D.N. Foster, and A.R. Strauch The 5′-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter J Biol Chem 265 1990 16667 16675
28. F. Fang, G. Antico, J. Zheng, and C.V. Clevenger Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter BMC Biotechnol 8 2008 11
29. P. Du, W.A. Kibbe, and S.M. Lin nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays Biol Direct 2 2007 16
30. P. Du, W.A. Kibbe, and S.M. Lin lumi: a pipeline for processing Illumina microarray Bioinformatics 24 2008 1547 1548
31. S.M. Lin, P. Du, W. Huber, and W.A. Kibbe Model-based variance-stabilizing transformation for Illumina microarray data Nucleic Acids Res 36 2008 e11
32. A. Milano, S.A. Pendergrass, J.L. Sargent, L.K. George, T.H. McCalmont, M.K. Connolly, and M.L. Whitfield Molecular subsets in the gene expression signatures of scleroderma skin PLoS One 3 2008 e2696
33. S. Takagawa, G. Lakos, Y. Mori, T. Yamamoto, K. Nishioka, and J. Varga Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma J Invest Dermatol 121 2003 41 50
34. G. Lakos, S. Takagawa, and J. Varga Animal models of scleroderma Methods Mol Med 102 2004 377 393
35. K.J. O'Donovan, and J.M. Baraban Major Egr3 isoforms are generated via alternate translation start sites and differ in their abilities to activate transcription Mol Cell Biol 19 1999 4711 4778
36. S. Collins, M.A. Lutz, P.E. Zarek, R.A. Anders, G.J. Kersh, and J.D. Powell Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3 Eur J Immunol 38 2008 528 536
37. J. Kumbrink, K.H. Kirsch, and J.P. Johnson EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin J Cell Biochem 111 2010 207 217
38. G. Dennis Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, and R.A. Lempicki DAVID: Database for annotation. Visualization, and Integrated Discovery Genome Biol 4 2003 P3
39. A.J. van der Slot, A.-M. Zuurmond, A.F.J. Bardoel, C. Wijmenga, H.E.H. Pruijs, D.O. Sillence, J. Brinckmann, D.J. Abraham, C.M. Black, N. Verzijl, J. DeGroot, R. Hanemaaijer, J.M. TeKoppele, T.W.J. Huizinga, and R.A. Bank Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis J Biol Chem 278 2003 40967 40972
40. M. Wu, and J. Varga In perspective: murine models of scleroderma Curr Rheumatol Rep 10 2008 173 182
41. S.L. Friedman, D. Sheppard, J.S. Duffield, and S. Violette Therapy for fibrotic diseases: nearing the starting line Sci Transl Med 5 2013 167sr1
42. S. Bhattacharyya, J. Wei, and J. Varga Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities Nat Rev Rheumatol 8 2012 42 54
43. S. Piera-Velazquez, and S.A. Jimenez Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases Fibrogenesis Tissue Repair 5 Suppl 1 2012 S7
44. G.P. Rodnan, E. Lipinski, and J. Luksick Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma Arthritis Rheum 22 1979 130 140
45. L.C. Eldredge, X.M. Gao, D.H. Quach, L. Li, X. Han, J. Lomasney, and W.G. Tourtellotte Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice Development 135 2008 2949 2957
46. J.H. Carter, J.M. Lefebvre, D.L. Wiest, and W.G. Tourtellotte Redundant role for early growth response transcriptional regulators in thymocyte differentiation and survival J Immunol 178 2007 6796 6805
47. J. Suehiro, T. Hamakubo, T. Kodama, W.C. Aird, and T. Minami Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3 Blood 115 2010 2520 2532
48. M. Safford, S. Collins, M.A. Lutz, A. Allen, C.T. Huang, J. Kowalski, A. Blackford, M.R. Horton, C. Drake, R.H. Schwartz, and J.D. Powell Egr-2 and Egr-3 are negative regulators of T cell activation Nat Immunol 6 2005 472 480
49. M.R. Muller, and A. Rao NFAT, immunity and cancer: a transcription factor comes of age Nat Rev Immunol 10 2010 645 656
50. B. Zhu, A.L. Symonds, J.E. Martin, D. Kioussis, D.C. Wraith, S. Li, and P. Wang Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease J Exp Med 205 2008 2295 2307
51. U. Sela, M. Dayan, R. Hershkoviz, O. Lider, and E. Mozes A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3 J Immunol 180 2008 1584 1591
52. S. Collins, A. Waickman, A. Basson, A. Kupfer, J.D. Licht, M.R. Horton, and J.D. Powell Regulation of CD4(+) and CD8(+) effector responses by Sprouty-1 PLoS One 7 2012 e49801
53. I. Valles, M.J. Pajares, V. Segura, E. Guruceaga, J. Gomez-Roman, D. Blanco, A. Tamura, L.M. Montuenga, and R. Pio Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer PLoS One 7 2012 e42086
54. D.K. Lee, T. Nguyen, G.P. O'Neill, R. Cheng, Y. Liu, A.D. Howard, N. Coulombe, C.P. Tan, A.T. Tang-Nguyen, S.R. George, and B.F. O'Dowd Discovery of a receptor related to the galanin receptors FEBS Lett 446 1999 103 107
55. A.I. Muir, L. Chamberlain, N.A. Elshourbagy, D. Michalovich, D.J. Moore, A. Calamari, P.G. Szekeres, H.M. Sarau, J.K. Chambers, P. Murdock, K. Steplewski, U. Shabon, J.E. Miller, S.E. Middleton, J.G. Darker, C.G. Larminie, S. Wilson, D.J. Bergsma, P. Emson, R. Faull, K.L. Philpott, and D.C. Harrison AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1 J Biol Chem 276 2001 28969 28975
56. C. Gonzalez Deepening on breast cancer metastasis: the ERalpha-mediated modulation of KISS/KISS1R system Endocrinology 154 2013 1959 1961
57. S. Hameed, C.N. Jayasena, and W.S. Dhillo Kisspeptin and fertility J Endocrinol 208 2011 97 105
58. M. Zajac, J. Law, D.D. Cvetkovic, M. Pampillo, L. McColl, C. Pape, G.M. Di Guglielmo, L.M. Postovit, A.V. Babwah, and M. Bhattacharya GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness PLoS One 6 2011 e21599
59. B. Hinz, S.H. Phan, V.J. Thannickal, M. Prunotto, A. Desmouliere, J. Varga, O. De Wever, M. Mareel, and G. Gabbiani Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Am J Pathol 180 2012 1340 1355